Emerging molecular networks in Burkitt's lymphoma

被引:11
作者
Mangani, Davide [1 ,2 ,3 ]
Roberti, Annalisa [1 ]
Rizzolio, Flavio [1 ,4 ]
Giordano, Antonio [1 ,5 ]
机构
[1] Temple Univ, Sbarro Inst Canc Res & Mol Med, Coll Sci & Technol, Ctr Biotechnol, Philadelphia, PA 19122 USA
[2] Human Hlth Fdn, Terni, PG, Italy
[3] Human Hlth Fdn, Spoleto, PG, Italy
[4] Natl Canc Inst IRCCS Aviano, Aviano, Italy
[5] Univ Siena, Dept Human Pathol & Oncol, I-53100 Siena, Italy
基金
欧洲研究理事会;
关键词
BURKITT'S LYMPHOMA; PROTEASOME; miRNA; C-MYC; CELL; EXPRESSION; PROLIFERATION; INACTIVATION; COOPERATE; LINES;
D O I
10.1002/jcb.24358
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Burkitt's lymphoma (BL), one of the most aggressive tumors affecting humans, characterized by the constitutive activation of the Myc oncogene together with the alteration of many other genetic and epigenetic factors. Among them, the INK4a/ARF locus has been well documented to play a central role in BL. Recently, we have discovered that simultaneous deregulation of both DNA methylation patterns and the ubiquitin-dependent proteolysis system is required to completely inactive the INK4/ARF locus, opening new possibilities for treating Burkitt's lymphoma. In this review, we integrate our discovery with the general view of BL and propose a new comprehensive approach to analyze and manage this aggressive disease. J. Cell. Biochem. 114: 3538, 2012. (C) 2012 Wiley Periodicals, Inc.
引用
收藏
页码:35 / 38
页数:4
相关论文
共 34 条
  • [1] Identification of the Human Mature B Cell miRNome
    Basso, Katia
    Sumazin, Pavel
    Morozov, Pavel
    Schneider, Christof
    Maute, Roy L.
    Kitagawa, Yukiko
    Mandelbaum, Jonathan
    Haddad, Joseph, Jr.
    Chen, Chang-Zheng
    Califano, Andrea
    Dalla-Favera, Riccardo
    [J]. IMMUNITY, 2009, 30 (05) : 744 - 752
  • [2] Ubiquitin-like protein conjugation and the ubiquitin-proteasome system as drug targets
    Bedford, Lynn
    Lowe, James
    Dick, Lawrence R.
    Mayer, R. John
    Brownell, James E.
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2011, 10 (01) : 29 - 46
  • [3] Pretargeted radioimmunotherapy of non-Hodgkin's lymphoma: Best of both worlds?
    Boerman, OC
    Oyen, WJG
    Corstens, FHM
    [J]. CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2000, 15 (01) : 1 - 5
  • [4] Gene-expression analysis identifies novel RBL2/p130 target genes in endemic Burkitt lymphoma cell lines and primary tumors
    De Falco, Giulia
    Leucci, Eleonora
    Lenze, Dido
    Piccaluga, Pier Paolo
    Claudio, Pier Paolo
    Onnis, Anna
    Cerino, Giovanna
    Nyagol, Joshua
    Mwanda, Walter
    Bellan, Cristiana
    Hummel, Michael
    Pileri, Stefano
    Tosi, Piero
    Stein, Harald
    Giordano, Antonio
    Leoncini, Lorenzo
    [J]. BLOOD, 2007, 110 (04) : 1301 - 1307
  • [5] Role of EBV in microRNA dysregulation in Burkitt lymphoma
    De Falco, Giulia
    Antonicelli, Giuseppina
    Onnis, Anna
    Lazzi, Stefano
    Bellan, Cristiana
    Leoncini, Lorenzo
    [J]. SEMINARS IN CANCER BIOLOGY, 2009, 19 (06) : 401 - 406
  • [6] WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION
    ELDEIRY, WS
    TOKINO, T
    VELCULESCU, VE
    LEVY, DB
    PARSONS, R
    TRENT, JM
    LIN, D
    MERCER, WE
    KINZLER, KW
    VOGELSTEIN, B
    [J]. CELL, 1993, 75 (04) : 817 - 825
  • [7] Burkitt's lymphoma: Clinicopathologic features and differential diagnosis
    Ferry, Judith A.
    [J]. ONCOLOGIST, 2006, 11 (04) : 375 - 383
  • [8] Burkitt Lymphoma: Pathogenesis and Immune Evasion
    God, Jason M.
    Haque, Azizul
    [J]. JOURNAL OF ONCOLOGY, 2010, 2010
  • [9] Burkitt lymphoma: the role of Epstein-Barr virus revisited
    Groemminger, Sebastian
    Mautner, Josef
    Bornkamm, Georg W.
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2012, 156 (06) : 719 - 729
  • [10] A biologic definition of Burkitt's lymphoma from transcriptional and genomic profiling
    Hummel, Michael
    Bentink, Stefan
    Berger, Hilmar
    Klapper, Wolfram
    Wessendorf, Swen
    Barth, Thomas F. E.
    Bernd, Heinz-Wolfram
    Cogliatti, Sergio B.
    Dierlamm, Judith
    Feller, Alfred C.
    Hansmann, Martin-Leo
    Haralambieva, Eugenia
    Harder, Lana
    Hasenclever, Dirk
    Kuehn, Michael
    Lenze, Dido
    Lichter, Peter
    Ignacio Martin-Subero, Jose
    Moeller, Peter
    Mueller-Hermelink, Hans-Konrad
    Ott, German
    Parwaresch, Reza M.
    Pott, Christiane
    Rosenwald, Andreas
    Rosolowski, Maciej
    Schwaenen, Carsten
    Stuerzenhofecker, Benjamin
    Szczepanowski, Monika
    Trautmann, Heiko
    Wacker, Hans-Heinrich
    Spang, Rainer
    Loeffler, Markus
    Truemper, Lorenz
    Stein, Harald
    Siebert, Reiner
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (23) : 2419 - 2430